| Financial Year |
March 31 2023 |
| Monetary Funds |
3,038,127,012.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
323,500,220.72 |
| Accounts Receivable |
15,441,190,009.64 |
| Advances to Suppliers |
1,139,040,381.06 |
| Other Receivables |
1,182,118,075.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,621,414,310.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
104,513,314.47 |
| Other Current Assets |
504,849,270.20 |
| Total Current Assets |
29,749,985,189.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
80,089,087.50 |
| Long-term Equity Investment |
2,591,487,576.51 |
| Investment Properties |
90,714,285.86 |
| Fixed Assetes |
2,320,444,959.79 |
| Under-construction Projects |
223,251,362.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
474,165,405.43 |
| R&D expenses |
433,428,325.83 |
| Goodwill |
1,123,822,084.62 |
| Long-Term Deferred and Prepaid Expenses |
123,439,817.41 |
| Deferred Income Tax Assets |
674,501,656.22 |
| Other Non-Current Assets |
442,726,936.31 |
| Sub-Total of Non-Current Assets |
8,860,059,934.19 |
| Total Assets |
38,610,045,123.38 |
| Short-Term Loans |
1,836,444,636.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,300,449,087.40 |
| Accounts Payable |
10,107,148,621.43 |
| Accounts Received In Advance |
1,632,818.94 |
| Employee Compensation Payable |
287,218,080.35 |
| Taxes Payable |
186,271,962.16 |
| Interest Payable |
-- |
| Dividend Payable |
5,199,883.73 |
| Other payables |
3,724,612,962.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
58,489,511.60 |
| Other Current Liabilities |
237,490,977.99 |
| Sub-Total of Current Liabilities |
19,244,639,654.00 |
| Long-term Loans |
3,568,356,829.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,023,563,290.65 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
14,693,121.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,871,407,114.68 |
| Total Liabilities |
25,116,046,768.68 |
| Paid-In Capital(Or Share Stock) |
1,495,879,748.00 |
| Capital Surplus |
2,052,839,804.88 |
| Surplus Reserve |
578,649,037.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,932,003,543.12 |
| Minority Stockholder's Interest |
2,409,126,995.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,084,871,359.58 |
| Owner's Equity（Stockholder's Equity） |
13,493,998,354.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,610,045,123.38 |
